In a study of human tumors growing in mice, University of Minnesota researchers have found that immune cells derived from human embryonic stem cells (hESCs) completely eliminated the tumors in 100 percent of mice tested.

These new killer cells could help develop cures for leukemia, lymphoma, prostate cancer, breast cancer and testicular cancer.